Study of optimal treatment duration with antihistamine in idiopathic urticaria patients
- Conditions
- Idiopathic urticaria
- Registration Number
- JPRN-UMIN000001163
- Lead Sponsor
- West Japan Urticaria Therapy Study Group
- Brief Summary
1. Less patients (70%) in the treated group suffered from recurrences than in the control group (90%). 2. Urticaria scores of patients in the last week of the study, and a number of patients who were either suffering from symptoms or taking medications in the treated group were lower than those in the control group. 3. No relation was observed between the recurrence rate and time to the treatment, time to be symptom-free from the onset of urticaria, and severity of urticaria before the treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 93
Not provided
1. Pregnant or lactating women or women of child bearing potential not using contraception 2. Patients with a history of hypersensitivity to fexofenadine hydrochloride 3. Patients who use medications that interfere with the efficacy evaluation (e.g., other antihistamines, drugs with anti-allergy action, systemic steroids etc.) 4. Others whom the physician judges are not suitable as subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cumulative recurrence rate at 3 months after relief of urticaria symptoms (signs)
- Secondary Outcome Measures
Name Time Method 1. Cumulative recurrence rate at 4 and 8 weeks after the relief of urticaria symptoms(signs) 2. Safety